Disorders of Sleep and Ventilatory Control in Prader-Willi Syndrome

Emily S Gillett, Iris A Perez, Emily S Gillett, Iris A Perez

Abstract

Prader-Willi syndrome (PWS) is an imprinted genetic disorder conferred by loss of paternal gene expression from chromosome 15q11.2-q13. Individuals with PWS have impairments in ventilatory control and are predisposed toward sleep disordered breathing due to a combination of characteristic craniofacial features, obesity, hypotonia, and hypothalamic dysfunction. Children with PWS progress from failure to thrive during infancy to hyperphagia and morbid obesity during later childhood and onward. Similarly, the phenotype of sleep disordered breathing in PWS patients also evolves over time from predominantly central sleep apnea in infants to obstructive sleep apnea (OSA) in older children. Behavioral difficulties are common and may make establishing effective therapy with continuous positive airway pressure (CPAP) more challenging when OSA persists after adenotonsillectomy. Excessive daytime sleepiness (EDS) is also common in patients with PWS and may continue after OSA is effectively treated. We describe here the characteristic ventilatory control deficits, sleep disordered breathing, and excessive daytime sleepiness seen in individuals with PWS. We review respiratory issues that may contribute to sudden death events in PWS patients during sleep and wakefulness. We also discuss therapeutic options for treating sleep disordered breathing including adenotonsillectomy, weight loss, and CPAP. Lastly, we discuss the benefits and safety considerations related to growth hormone therapy.

Keywords: Prader-Willi syndrome; adenotonsillectomy; bariatric surgery; growth hormone; hypocretin; non-invasive ventilation; obesity; obstructive sleep apnea; sleep disorders; ventilatory control.

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Donaldson M.D., Chu C.E., Cooke A., Wilson A., Greene S.A., Stephenson J.B. The Prader-Willi syndrome. Arch. Dis. Child. 1994;70:58–63. doi: 10.1136/adc.70.1.58.
    1. Thomson A.K., Glasson E.J., Bittles A.H. A long-term population-based clinical and morbidity review of Prader-Willi syndrome in Western Australia. J. Intellect. Disabil. Res. 2006;50:69–78. doi: 10.1111/j.1365-2788.2005.00770.x.
    1. Cassidy S.B., Schwartz S., Miller J.L., Driscoll D.J. Prader-Willi syndrome. Genet. Med. 2012;14:10–26. doi: 10.1038/gim.0b013e31822bead0.
    1. Ledbetter D.H., Riccardi V.M., Airhart S.D., Strobel R.J., Keenan B.S., Crawford J.D. Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. N. Engl. J. Med. 1981;304:325–329. doi: 10.1056/NEJM198102053040604.
    1. Butler M.G., Palmer C.G. Parental origin of chromosome 15 deletion in Prader-Willi syndrome. Lancet (Lond. Engl.) 1983;1:1285–1286. doi: 10.1016/S0140-6736(83)92745-9.
    1. Nicholls R.D., Knoll J.H., Butler M.G., Karam S., Lalande M. Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome. Nature. 1989;342:281–285. doi: 10.1038/342281a0.
    1. Holm V.A., Cassidy S.B., Butler M.C., Hanchett J.M., Greenswag L.R., Whitman B.Y., Greenberg F. Prader-Willi Syndrome: Consensus Diagnostic Criteria. Pediatrics. 1993;91:398–402.
    1. Angulo M.A., Butler M.G., Cataletto M.E. Prader-Willi syndrome: A review of clinical, genetic, and endocrine findings. J. Endocrinol. Invest. 2015;38:1249–1263. doi: 10.1007/s40618-015-0312-9.
    1. Sedky K., Bennett D.S., Pumariega A. Prader Willi syndrome and obstructive sleep apnea: Co-occurrence in the pediatric population. J. Clin. Sleep Med. 2014;10:403–409. doi: 10.5664/jcsm.3616.
    1. Pavone M., Caldarelli V., Khirani S., Colella M., Ramirez A., Aubertin G., Crinò A., Brioude F., Gastaud F., Beydon N., et al. Sleep disordered breathing in patients with Prader-Willi syndrome: A multicenter study. Pediatr. Pulmonol. 2015;50:1354–1359. doi: 10.1002/ppul.23177.
    1. Whittington J.E., Holland A.J., Webb T., Butler J., Clarke D., Boer H. Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J. Med. Genet. 2001;38:792–798. doi: 10.1136/jmg.38.11.792.
    1. Tauber M., Diene G., Molinas C., Hébert M. Review of 64 cases of death in children with Prader-Willi syndrome (PWS) Am. J. Med. Genet. A. 2008;146A:881–887. doi: 10.1002/ajmg.a.32131.
    1. Arens R., Gozal D., Omlin K.J., Livingston F.R., Liu J., Keens T.G., Ward S.L. Hypoxic and hypercapnic ventilatory responses in Prader-Willi syndrome. J. Appl. Physiol. 1994;77:2224–2230.
    1. Gozal D., Arens R., Omlin K.J., Ward S.L., Keens T.G. Absent peripheral chemosensitivity in Prader-Willi syndrome. J. Appl. Physiol. 1994;77:2231–2236.
    1. Lindgren A.C., Hellström L.G., Ritzén E.M., Milerad J. Growth hormone treatment increases CO(2) response, ventilation and central inspiratory drive in children with Prader-Willi syndrome. Eur. J. Pediatr. 1999;158:936–940. doi: 10.1007/s004310051246.
    1. Waldrop T.G. Posterior hypothalamic modulation of the respiratory response to CO2 in cats. Pflügers Arch. Eur. J. Physiol. 1991;418:7–13. doi: 10.1007/BF00370445.
    1. Katz-Salamon M., Lindgren A., Cohen G. The effect of growth hormone on sleep-related cardio-respiratory control in Prader-Willi syndrome. Acta Paediatr. 2012;101:643–648. doi: 10.1111/j.1651-2227.2012.02638.x.
    1. Hákonarson H., Moskovitz J., Daigle K.L., Cassidy S.B., Cloutier M.M. Pulmonary function abnormalities in Prader-Willi syndrome. J. Pediatr. 1995;126:565–570. doi: 10.1016/S0022-3476(95)70350-0.
    1. McPhail G.L., Ehsan Z., Howells S.A., Boesch R.P., Fenchel M.C., Szczesniak R., Jain V., Agabegi S., Sturm P., Wall E., et al. Obstructive lung disease in children with idiopathic scoliosis. J. Pediatr. 2015;166:1018–1021. doi: 10.1016/j.jpeds.2014.12.070.
    1. Poponick J.M., Jacobs I., Supinski G., DiMarco A.F. Effect of upper respiratory tract infection in patients with neuromuscular disease. Am. J. Respir. Crit. Care Med. 1997;156:659–664. doi: 10.1164/ajrccm.156.2.9611029.
    1. Stevenson D.A., Anaya T.M., Clayton-Smith J., Hall B.D., Van Allen M.I., Zori R.T., Zackai E.H., Frank G., Clericuzio C.L. Unexpected death and critical illness in Prader-Willi syndrome: Report of ten individuals. Am. J. Med. Genet. A. 2004;124A:158–164. doi: 10.1002/ajmg.a.20370.
    1. Schrander-Stumpel C.T.R.M., Curfs L.M.G., Sastrowijoto P., Cassidy S.B., Schrander J.J.P., Fryns J.-P. Prader-Willi syndrome: Causes of death in an international series of 27 cases. Am. J. Med. Genet. A. 2004;124A:333–338. doi: 10.1002/ajmg.a.20371.
    1. Grugni G., Crinò A., Bosio L., Corrias A., Cuttini M., De Toni T., Di Battista E., Franzese A., Gargantini L., Greggio N., et al. The Italian National Survey for Prader-Willi syndrome: An epidemiologic study. Am. J. Med. Genet. A. 2008;146A:861–872. doi: 10.1002/ajmg.a.32133.
    1. Zerah F., Harf A., Perlemuter L., Lorino H., Lorino A.M., Atlan G. Effects of obesity on respiratory resistance. Chest. 1993;103:1470–1476. doi: 10.1378/chest.103.5.1470.
    1. Pelosi P., Croci M., Ravagnan I., Tredici S., Pedoto A., Lissoni A., Gattinoni L. The effects of body mass on lung volumes, respiratory mechanics, and gas exchange during general anesthesia. Anesth. Analg. 1998;87:654–660.
    1. Robinson P.D. Obesity and its impact on the respiratory system. Paediatr. Respir. Rev. 2014;15:219–226. doi: 10.1016/j.prrv.2014.06.003.
    1. Rubinstein I., Zamel N., DuBarry L., Hoffstein V. Airflow limitation in morbidly obese, nonsmoking men. Ann. Intern. Med. 1990;112:828–832. doi: 10.7326/0003-4819-112-11-828.
    1. Lazarus R., Sparrow D., Weiss S.T. Effects of obesity and fat distribution on ventilatory function: The normative aging study. Chest. 1997;111:891–898. doi: 10.1378/chest.111.4.891.
    1. Lazarus R., Colditz G., Berkey C.S., Speizer F.E. Effects of body fat on ventilatory function in children and adolescents: Cross-sectional findings from a random population sample of school children. Pediatr. Pulmonol. 1997;24:187–194. doi: 10.1002/(SICI)1099-0496(199709)24:3<187::AID-PPUL4>;2-K.
    1. Li A.M., Chan D., Wong E., Yin J., Nelson E.A.S., Fok T.F. The effects of obesity on pulmonary function. Arch. Dis. Child. 2003;88:361–363. doi: 10.1136/adc.88.4.361.
    1. Faria A.G., Ribeiro M.A.G.O., Marson F.A.L., Schivinski C.I.S., Severino S.D., Ribeiro J.D., Barros Filho A.A. Effect of exercise test on pulmonary function of obese adolescents. J. Pediatr. (Rio J) 2014;90:242–249. doi: 10.1016/j.jped.2013.08.005.
    1. Bosisio E., Sergi M., di Natale B., Chiumello G. Ventilatory volumes, flow rates, transfer factor and its components (membrane component, capillary volume) in obese adults and children. Respiration. 1984;45:321–326. doi: 10.1159/000194638.
    1. Inselma L.S., Milanese A., Deurloo A. Effect of obesity on pulmonary function in children. Pediatr. Pulmonol. 1993;16:130–137. doi: 10.1002/ppul.1950160209.
    1. Marcus C.L., Curtis S., Koerner C.B., Joffe A., Serwint J.R., Loughlin G.M. Evaluation of pulmonary function and polysomnography in obese children and adolescents. Pediatr. Pulmonol. 1996;21:176–183. doi: 10.1002/(SICI)1099-0496(199603)21:3<176::AID-PPUL5>;2-O.
    1. Santamaria F., Montella S., Greco L., Valerio G., Franzese A., Maniscalco M., Fiorentino G., Peroni D., Pietrobelli A., De Stefano S., et al. Obesity duration is associated to pulmonary function impairment in obese subjects. Obesity (Silver Spring) 2011;19:1623–1628. doi: 10.1038/oby.2011.1.
    1. Beuther D.A., Sutherland E.R. Overweight, obesity, and incident asthma: A meta-analysis of prospective epidemiologic studies. Am. J. Respir. Crit. Care Med. 2007;175:661–666. doi: 10.1164/rccm.200611-1717OC.
    1. Kim S.-H., Sutherland E.R., Gelfand E.W. Is there a link between obesity and asthma? Allergy Asthma Immunol. Res. 2014;6:189–195. doi: 10.4168/aair.2014.6.3.189.
    1. Gibson N., Johnston K., Bear N., Stick S., Logie K., Hall G.L. Expiratory flow limitation and breathing strategies in overweight adolescents during submaximal exercise. Int. J. Obes. (Lond.) 2014;38:22–26. doi: 10.1038/ijo.2013.137.
    1. Lumeng J.C., Chervin R.D. Epidemiology of pediatric obstructive sleep apnea. Proc. Am. Thorac. Soc. 2008;5:242–252. doi: 10.1513/pats.200708-135MG.
    1. Richards A., Quaghebeur G., Clift S., Holland A., Dahlitz M., Parkes D. The upper airway and sleep apnoea in the Prader-Willi syndrome. Clin. Otolaryngol. Allied Sci. 1994;19:193–197. doi: 10.1111/j.1365-2273.1994.tb01213.x.
    1. Eiholzer U. Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS. Horm. Res. 2005;63:33–39. doi: 10.1159/000082745.
    1. Schlüter B., Buschatz D., Trowitzsch E., Aksu F., Andler W. Respiratory control in children with Prader-Willi syndrome. Eur. J. Pediatr. 1997;156:65–68. doi: 10.1007/s004310050555.
    1. Sharkia M., Michaud S., Berthier M.-T., Giguère Y., Stewart L., Deladoëy J., Deal C., Van Vliet G., Chanoine J.-P. Thyroid function from birth to adolescence in Prader-Willi syndrome. J. Pediatr. 2013;163:800–805. doi: 10.1016/j.jpeds.2013.03.058.
    1. Tauber M., Barbeau C., Jouret B., Pienkowski C., Malzac P., Moncla A., Rochiccioli P. Auxological and Endocrine Evolution of 28 Children with Prader-Willi Syndrome: Effect of GH Therapy in 14 Children. Horm. Res. Paediatr. 2001;53:279–287. doi: 10.1159/000053184.
    1. Butler M.G., Theodoro M., Skouse J.D. Thyroid function studies in Prader-Willi syndrome. Am. J. Med. Genet. Part A. 2007;143A:488–492. doi: 10.1002/ajmg.a.31683.
    1. Van Vliet G., Deal C.L., Crock P.A., Robitaille Y., Oligny L.L. Sudden death in growth hormone-treated children with Prader-Willi syndrome. J. Pediatr. 2004;144:129–131. doi: 10.1016/j.jpeds.2003.09.049.
    1. Miller J., Silverstein J., Shuster J., Driscoll D.J., Wagner M. Short-term effects of growth hormone on sleep abnormalities in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 2006;91:413–417. doi: 10.1210/jc.2005-1279.
    1. Nixon G.M., Rodda C.P., Davey M.J. Longitudinal association between growth hormone therapy and obstructive sleep apnea in a child with Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 2011;96:29–33. doi: 10.1210/jc.2010-1445.
    1. Fillion M., Deal C., Van Vliet G. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome. J. Pediatr. 2009;154:230–233. doi: 10.1016/j.jpeds.2008.07.058.
    1. Al-Saleh S., Al-Naimi A., Hamilton J., Zweerink A., Iaboni A., Narang I. Longitudinal evaluation of sleep-disordered breathing in children with Prader-Willi syndrome during 2 years of growth hormone therapy. J. Pediatr. 2013;162:263–268. doi: 10.1016/j.jpeds.2012.07.042.
    1. Berini J., Spica Russotto V., Castelnuovo P., Di Candia S., Gargantini L., Grugni G., Iughetti L., Nespoli L., Nosetti L., Padoan G., et al. Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology (ISPED) Growth hormone therapy and respiratory disorders: Long-term follow-up in PWS children. J. Clin. Endocrinol. Metab. 2013;98:E1516–E1523. doi: 10.1210/jc.2013-1831.
    1. Eiholzer U., Nordmann Y., L’Allemand D. Fatal outcome of sleep apnoea in PWS during the initial phase of growth hormone treatment. A case report. Horm. Res. 2002;58(Suppl. S3):24–26. doi: 10.1159/000066478.
    1. Grugni G., Livieri C., Corrias A., Sartorio A., Crinò A. Death during GH therapy in children with Prader-Willi syndrome: Description of two new cases. J. Endocrinol. Invest. 2005;28:554–557. doi: 10.1007/BF03347245.
    1. Riedl S., Blümel P., Zwiauer K., Frisch H. Death in two female Prader-Willi syndrome patients during the early phase of growth hormone treatment. Acta Paediatr. 2005;94:974–977. doi: 10.1080/08035250510027110.
    1. Nagai T., Obata K., Tonoki H., Temma S., Murakami N., Katada Y., Yoshino A., Sakazume S., Takahashi E., Sakuta R., et al. Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment. Am. J. Med. Genet. A. 2005;136:45–48. doi: 10.1002/ajmg.a.30777.
    1. Bakker B., Maneatis T., Lippe B. Sudden death in Prader-Willi syndrome: Brief review of five additional cases. Concerning the article by U. Eiholzer et al.: Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in childre. Horm. Res. 2007;67:203–204. doi: 10.1159/000097928.
    1. Bridges N. What is the value of growth hormone therapy in Prader Willi syndrome? Arch. Dis. Child. 2014;99:166–170. doi: 10.1136/archdischild-2013-303760.
    1. Deal C.L., Tony M., Höybye C., Allen D.B., Tauber M., Christiansen J.S., 2011 Growth Hormone in Prader-Willi syndrome Clinical Care Guidelines Workshop Participants GrowthHormone Research Society workshop summary: Consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 2013;98:E1072–E1087. doi: 10.1210/jc.2012-3888.
    1. Vandeleur M., Davey M.J., Nixon G.M. Are sleep studies helpful in children with Prader-Willi syndrome prior to commencement of growth hormone therapy? J. Paediatr. Child Health. 2013;49:238–241. doi: 10.1111/jpc.12109.
    1. McCandless S.E., The Committee on Genetics Health Supervision for Children With Prader-Willi Syndrome. Pediatrics. 2011;127:195–204.
    1. Aycan Z., Baş V.N. Prader-Willi syndrome and growth hormone deficiency. J. Clin. Res. Pediatr. Endocrinol. 2014;6:62–67. doi: 10.4274/jcrpe.1228.
    1. Salvatoni A., Berini J., Chiumello G., Crinò A., Di Candia S., Gargantini L., Grugni G., Iughetti L., Luce A., Musolino G., et al. Letter to the Editor POI: A Score to Modulate GH Treatment in Children with Prader-Willi Syndrome. Horm Res Paediatr. 2012;78:201–202. doi: 10.1159/000342649.
    1. Cohen M., Hamilton J., Narang I. Clinically important age-related differences in sleep related disordered breathing in infants and children with Prader-Willi Syndrome. PLoS ONE. 2014;9:e101012. doi: 10.1371/journal.pone.0101012.
    1. Livingston F.R., Arens R., Bailey S.L., Keens T.G., Ward S.L. Hypercapnic arousal responses in Prader-Willi syndrome. Chest. 1995;108:1627–1631. doi: 10.1378/chest.108.6.1627.
    1. Arens R., Gozal D., Burrell B.C., Bailey S.L., Bautista D.B., Keens T.G., Ward S.L. Arousal and cardiorespiratory responses to hypoxia in Prader-Willi syndrome. Am. J. Respir. Crit. Care Med. 1996;153:283–287. doi: 10.1164/ajrccm.153.1.8542130.
    1. Yee B.J., Buchanan P.R., Mahadev S., Banerjee D., Liu P.Y., Phillips C., Loughnan G., Steinbeck K., Grunstein R.R. Assessment of sleep and breathing in adults with prader-willi syndrome: A case control series. J. Clin. Sleep Med. 2007;3:713–718.
    1. Urquhart D.S., Gulliver T., Williams G., Harris M.A., Nyunt O., Suresh S. Central sleep-disordered breathing and the effects of oxygen therapy in infants with Prader-Willi syndrome. Arch. Dis. Child. 2013;98:592–595. doi: 10.1136/archdischild-2012-303441.
    1. Meyer S.L., Splaingard M., Repaske D.R., Zipf W., Atkins J., Jatana K. Outcomes of adenotonsillectomy in patients with Prader-Willi syndrome. Arch. Otolaryngol. Head Neck Surg. 2012;138:1047–1051. doi: 10.1001/2013.jamaoto.64.
    1. Pavone M., Paglietti M.G., Petrone A., Crinò A., De Vincentiis G.C., Cutrera R. Adenotonsillectomy for obstructive sleep apnea in children with Prader-Willi syndrome. Pediatr. Pulmonol. 2006;41:74–79. doi: 10.1002/ppul.20334.
    1. Crockett D.J., Ahmed S.R., Sowder D.R., Wootten C.T., Chinnadurai S., Goudy S.L. Velopharyngeal dysfunction in children with Prader-Willi syndrome after adenotonsillectomy. Int. J. Pediatr. Otorhinolaryngol. 2014;78:1731–1734. doi: 10.1016/j.ijporl.2014.07.034.
    1. Arzt M., Young T., Finn L., Skatrud J.B., Bradley T.D. Association of sleep-disordered breathing and the occurrence of stroke. Am. J. Respir. Crit. Care Med. 2005;172:1447–1451. doi: 10.1164/rccm.200505-702OC.
    1. Somers V.K., White D.P., Amin R., Abraham W.T., Costa F., Culebras A., Daniels S., Floras J.S., Hunt C.E., Olson L.J., et al. Sleep apnea and cardiovascular disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on. J. Am. Coll. Cardiol. 2008;52:686–717. doi: 10.1016/j.jacc.2008.05.002.
    1. Lee P.-C., Hwang B., Soong W.-J., Meng C.C.L. The specific characteristics in children with obstructive sleep apnea and cor pulmonale. Sci. World J. 2012;2012:757283. doi: 10.1100/2012/757283.
    1. DeMarcantonio M.A., Darrow D.H., Gyuricsko E., Derkay C.S. Obstructive sleep disorders in Prader-Willi syndrome: The role of surgery and growth hormone. Int. J. Pediatr. Otorhinolaryngol. 2010;74:1270–1272. doi: 10.1016/j.ijporl.2010.08.001.
    1. Nixon G.M., Brouillette R.T. Sleep and breathing in Prader-Willi syndrome. Pediatr. Pulmonol. 2002;34:209–217. doi: 10.1002/ppul.10152.
    1. Fong A.K.W., Wong S.K.H., Lam C.C.H., Ng E.K.W. Ghrelin level and weight loss after laparoscopic sleeve gastrectomy and gastric mini-bypass for Prader-Willi syndrome in Chinese. Obes. Surg. 2012;22:1742–1745. doi: 10.1007/s11695-012-0725-x.
    1. Alqahtani A.R., Elahmedi M.O., Al Qahtani A.R., Lee J., Butler M.G. Laparoscopic sleeve gastrectomy in children and adolescents with Prader-Willi syndrome: A matched-control study. Surg. Obes. Relat. Dis. 2016;12:100–110. doi: 10.1016/j.soard.2015.07.014.
    1. Messersmith N.V., Slifer K.J., Pulbrook-Vetter V., Bellipanni K. Interdisciplinary behavioral intervention for life-threatening obesity in an adolescent with Prader-Willi syndrome—A case report. J. Dev. Behav. Pediatr. 2008;29:129–134. doi: 10.1097/DBP.0b013e31815f24bd.
    1. Lau E.Y.Y., Choi E.W.M., Lai E.S.K., Lau K.N.T., Au C.T., Yung W.H., Li A.M. Working memory impairment and its associated sleep-related respiratory parameters in children with obstructive sleep apnea. Sleep Med. 2015;16:1109–1115. doi: 10.1016/j.sleep.2015.04.025.
    1. Landau Y.E., Bar-Yishay O., Greenberg-Dotan S., Goldbart A.D., Tarasiuk A., Tal A. Impaired behavioral and neurocognitive function in preschool children with obstructive sleep apnea. Pediatr. Pulmonol. 2012;47:180–188. doi: 10.1002/ppul.21534.
    1. Bourke R., Anderson V., Yang J.S.C., Jackman A.R., Killedar A., Nixon G.M., Davey M.J., Walker A.M., Trinder J., Horne R.S.C. Cognitive and academic functions are impaired in children with all severities of sleep-disordered breathing. Sleep Med. 2011;12:489–496. doi: 10.1016/j.sleep.2010.11.010.
    1. O’Donoghue F.J., Camfferman D., Kennedy J.D., Martin A.J., Couper T., Lack L.D., Lushington K., McEvoy R.D. Sleep-disordered breathing in Prader-Willi syndrome and its association with neurobehavioral abnormalities. J. Pediatr. 2005;147:823–829. doi: 10.1016/j.jpeds.2005.07.021.
    1. Harris J.C., Allen R.P. Is excessive daytime sleepiness characteristic of Prader-Willi syndrome? The effects of weight change. Arch. Pediatr. Adolesc. Med. 1996;150:1288–1293. doi: 10.1001/archpedi.1996.02170370066011.
    1. Cotton S., Richdale A. Brief report: Parental descriptions of sleep problems in children with autism, Down syndrome, and Prader-Willi syndrome. Res. Dev. Disabil. 2006;27:151–161. doi: 10.1016/j.ridd.2004.12.003.
    1. Manni R., Politini L., Nobili L., Ferrillo F., Livieri C., Veneselli E., Biancheri R., Martinetti M., Tartara A. Hypersomnia in the Prader Willi syndrome: Clinical-electrophysiological features and underlying factors. Clin. Neurophysiol. 2001;112:800–805. doi: 10.1016/S1388-2457(01)00483-7.
    1. Omokawa M., Ayabe T., Nagai T., Imanishi A., Omokawa A., Nishino S., Sagawa Y., Shimizu T., Kanbayashi T. Decline of CSF orexin (hypocretin) levels in Prader-Willi syndrome. Am. J. Med. Genet. A. 2016;170:1181–1186. doi: 10.1002/ajmg.a.37542.
    1. Nishino S., Ripley B., Overeem S., Lammers G.J., Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet (Lond. Engl.) 2000;355:39–40. doi: 10.1016/S0140-6736(99)05582-8.
    1. Sateia M., editor. International Classification of Sleep Disorders. 3rd ed. American Academy of Sleep Medicine; Darien, IL, USA: 2014.
    1. Nevsimalova S., Vankova J., Stepanova I., Seemanova E., Mignot E., Nishino S. Hypocretin deficiency in Prader-Willi syndrome. Eur. J. Neurol. 2005;12:70–72. doi: 10.1111/j.1468-1331.2004.00969.x.
    1. De Cock V.C., Diene G., Molinas C., Masson V.D.-L., Kieffer I., Mimoun E., Tiberge M., Tauber M. Efficacy of modafinil on excessive daytime sleepiness in Prader-Willi syndrome. Am. J. Med. Genet. A. 2011;155A:1552–1557. doi: 10.1002/ajmg.a.34047.
    1. Weselake S.V., Foulds J.L., Couch R., Witmans M.B., Rubin D., Haqq A.M. Prader-Willi syndrome, excessive daytime sleepiness, and narcoleptic symptoms: A case report. J. Med. Case Rep. 2014;8:127. doi: 10.1186/1752-1947-8-127.
    1. Carrel A.L., Myers S.E., Whitman B.Y., Eickhoff J., Allen D.B. Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome. J. Clin. Endocrinol. Metab. 2010;95:1131–1136. doi: 10.1210/jc.2009-1389.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir